A novel electrochemical immunosensor for the quantification of a-feto protein (AFP) using a nanocomposite of manganese(IV) oxide nanorods (MnO 2 NRs) and gold nanoparticles (AuNPs) as the immobilisation layer is presented. The MnO 2 NRs was synthesised using a hydrothermal method and AuNPs were electrodeposited on a glassy carbon electrode surface. The MnO 2 NRs were characterised with scanning electron microscopy (SEM), high-resolution transmission electron microscopy (HRTEM) and X-ray powder diffraction (XRD). Cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) were used to characterise the immunosensor at each stage of the biosensor preparation. The MnO 2 nanorods and AuNPs were applied as the immobilisation layer to efficiently capture the antibodies and amplify the electrochemical signal. Under optimised conditions, the fabricated immunosensor was utilised for the quantification of AFP with a wide dynamic range of 0.005 to 500 ng mL À1 and detection limits of 0.00276 ng mL À1 and 0.00172 ng mL À1 (S/N ¼ 3) were obtained from square wave anodic stripping voltammetry and EIS respectively. The nanocomposite modifier enhanced the immunosensor performance. More so, this label-free immunosensor possesses good stability over a period of two weeks when stored at 4 C and was selective in the presence of some interfering species.
Introduction
Alpha-feto protein (AFP) is a single-stranded glycoprotein with a molecular weight of 70 000 Da; it is produced by the yolk sac and fetal liver. 1 It is an important tumour biomarker oen employed for early diagnosis of liver cancer. The concentration of AFP in serum of healthy adults is 25 ng mL À1 but this concentration increases signicantly in patients with cancer of the liver. 1 Thus, the quantication of AFP in human serum plays a signicant role in the management of liver carcinoma.
Different analytical techniques such as radioimmunoassay, and chemiluminescence 5 have been reported for the quantication of AFP. Unfortunately, some of the problems that limit their applications include high turnaround time; high cost, instruments that are not easily operated and requires expertise. On the other hand, electrochemical methods (including electrochemical immunosensors) present themselves as low cost, portable, user-friendly, fast, sensitive, simple and eld-borne analytical tool. 6 These advantages lend electrochemical techniques to environmental analysis, 7 biotechnology, 8 pharmaceutical chemistry, 9 clinical diagnosis 10 and food industry.
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A label-free electrochemical immunosensor involves a direct monitoring of an immunocomplex reaction between antibody and antigen with the advantage of avoiding mediators and tagging. The effective immobilisation of the biomolecules is a crucial step in label-free (and labelled) electrochemical immunosensor. To achieve this, a modier is carefully selected as a platform or immobilisation layer to assist in capturing the bioreceptor on the electrode and to favour the formation of immunocomplex reaction between the antibody and the antigen. Interestingly, covalent bonding has been reported to be the most explored method in the immobilisation of biomolecules. And glutaraldehyde along with 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide/N-hydroxysuccinimide (EDC/NHS) is the most prominent cross-linking agents used.
12, 13 The use of cross linkers in immunosensor fabrications increases the step in the biosensor preparation and creates the possibility of introducing bonds that may hinder the bio-recognition process and thus a deviation from biomimicry.
14 It is therefore necessary to utilise materials that are biocompatible (that will not hinder the biological integrity of the biomolecules) and which can increase the electrode surface area and enhance conductivity. In this light, a composite of gold nanoparticles (AuNPs) and manganese(IV) oxide nanorods (MnO 2 NRs) was utilised for the rst time as a platform for the reported immunosensor.
Gold nanoparticles (AuNPs) have been used in different analytical elds because of their nanoscale size, large surface area, high electron density, rich surface chemistry and biocompatibility properties. 15 These properties have rendered gold nanoparticles a material of choice in biosensors, 16, 17 
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In another report, gold nanoparticles and graphene chitosan nanocomposite were employed for the construction of a labelfree electrochemical immunosensor for carcinoembryonic antigen.
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Similarly, a Prussian blue-chitosan-gold nanocomposite lm was explored for the fabrication of an amperometric immunosensor for histamine detection.
17
Manganese(IV) oxide nanorods (MnO 2 NRs), though less utilised compared to AuNPs, possess interesting properties such as catalysis, low cost, high surface area, environment-friendliness and excellent electrochemical properties. 28 37 have been reported for the preparation of MnO 2 . The advantage of hydrothermal synthetic routes over others is the ability to produce a variety of nanostructured materials, which ranges from nanoparticles to nanorods and nanotubes. The shapes and sizes can be easily controlled by optimising the reaction temperature and time. The reported MnO 2 NRs was synthesised via the hydrothermal route.
Reports on the electrochemical applications of MnO 2 NRs especially in biosensors are scanty. Wang et al. reported a nonenzymatic biosensor for L-cysteine using copper nanoparticles and manganese dioxide-multiwalled carbon nanotubes. 38 Other reports include the use of MnO 2 in the sensing of hydrogen peroxide in living cells 39 and choline with choline oxidase as bioreceptor. 40 These recent reports suggest that this material has a potential for biosensor development.
Thus, MnO 2 was employed in this work, owing to its nanosize (for increase surface area), conductivity (enhancing of electron/ charge ow) and affinity for the thiol residue in the antibody.
38
AuNP was used to sandwich the MnO 2 further onto the electrode by electrodeposition thus preventing leaching of the MnO 2 . The sandwich creates a possible metal-metal interaction between the MnO 2 and AuNP forming a continuous nano-network that facilitated enhanced electron transfer. In a similar manner to MnO 2 , AuNPs has affinity for sulphur residue in the amino acid sulphur atoms in the AFP antibody and this improved the immobilisation capacity of the modied electrode. 15 
Experimental

Materials and instruments
Alpha-feto protein and anti-AFP (monoclonal) were bought from Celtic Diagnostic (South Africa). Ascorbic acid, urea, bovine serum albumin (BSA), prostate-specic antigen (PSA), human immunoglobulin, carcinoembryonic antigen (CEA), Na 2 HPO 4 , K 3 Fe(CN) 6 , NaH 2 PO 4 , HAuCl 4 , KMnO 4 and KCl were bought from Sigma Aldrich (South Africa). All chemicals were used as received and all solutions were prepared with ultra-pure water.
The following techniques/instruments were used for characterisation: X-ray diffractometry on a Rigaku Smartlab X-ray diffractometer (USA). Electron micrographs were taken with a scanning electron microscope (TESCAN, Vega 3 XMU, Czech Republic), transmission electron microscopy (JEOL 2100 HRTEM 200 V, Japan). Ivium Compactstat potentiostat (Netherlands) was used for all the electrochemical experiments in a three-electrode system cell comprising glassy carbon as a working electrode, Ag/ AgCl (3 M KCl) as a reference electrode and platinum wire as a counter electrode. Cyclic voltammetry (CV) measurements were carried out at a scan rate of 50 mV s À1 and a potential range of À0.3 V to 1.0 V. The parameters used for the electrochemical impedance spectroscopy measurements are frequency range of 100 kHz to 100 mHz and a bias potential of 0.22 V.
Synthesis of manganese(IV) nanorods (MnO 2 NRs)
The MnO 2 NRs was synthesised using method reported in the literature with slight modications. 41 Briey, 1.26 g of KMnO 4 and 0.5 g of MnSO 4 $H 2 O were dissolved in 40 mL of water. The resulting solution was transferred into a Teon-lined stainless steel autoclave (50 mL) and heated at 160 C for 12 h. The dark brown precipitate formed was centrifuged, washed with ultrapure water and ethanol three times and nally dried at 80 C. Eqn (1) represents the reaction involved in the formation of MnO 2 NRs.
Scheme 1 The scheme for the fabrication of the immunosensor.
Preparation of the immunosensor
A glassy carbon electrode (GCE) was polished with different diameters of aluminium slurry (1.0, 0.3 and 0.05 mm) and rinsed ultrasonically in water and ethanol. The cleaned electrode was le to dry at ambient temperature before use. A 30 mg of the synthesised MnO 2 was dispersed in 5 mL of dimethylformamide and sonicated for 1 h. Thereaer, a 20 mL of the ultrasonicated solution was dropped on the GCE and allowed to dry overnight at ambient temperature. This electrode was labelled GCE-MnO 2 -NRs. Gold nanoparticles was electrodeposited onto the GCEMnO 2 NRs from a 10 mM HAuCl 4 solution by cycling a potential from À400 mV to 1100 mV at a scan rate of 50 mV s À1 for ten cycles. 42 This electrode was labelled as GCE-MnO 2 NRs@AuNPs. The immunosensor was prepared by immersing the GCEMnO 2 NRs@AuNPs in a 500 ng mL À1 of 25 mL anti-AFP solution overnight at 4 C. Finally, the modied electrode was incubated in 0.25% bovine serum albumin solution for 2 h to prevent nonspecic binding between antigen and electrode surface. The step-wise preparation of the immunosensor is presented in Scheme 1.
Results and discussion
The SEM image of MnO 2 NRs shown in Fig. 1a reveals a rodshaped morphology, which was further conrmed by HRTEM image (Fig. 1b) . The crystallographic structure of MnO 2 NRs was examined using XRD (Fig. 1c) 
, (220), (310), (221), (301), (411), (600), (521), (002) and (541) plane diffraction of a-MnO 2 with a pure tetragonal phase (JCPDS no. 44-0141). A similar MnO 2 XRD pattern has been documented in the literature. 43 The EDX spectrum in Fig. 1d further conrms the presence of manganese and oxygen in the MNO 2 NRs. The morphology and size distribution of AuNPs were characterised as shown in Fig. 1e and f, these gures revealed that AuNPs are spherical and well dispersed on the electrode. The size distribution of the AuNPs is small and majority falls within the range from 5 to 31 nm. Based on the statistical analysis of hundred particles, the average diameter of the AuNPs obtained was about 17 nm (Fig. 1e) .
Electrochemical characterisation of the immunosensor assembly
Electrochemical characterisations were carried out with CV and EIS in 1 mM [Fe(CN) 6 ] 3À/4À in 0.1 M KCl. The bare GCE showed the characteristic ferrocyanide peak (Fig. 2Aa ). The peak current signal increased by 75% on modifying the bare GCE with MnO 2 NRs (Fig. 2Ab ). This must have been as a result of the electrocatalytic property of manganese(IV) oxide nanorods, which helps to facilitate electron transfer at the electrode- solution interface. Similarly, 83% current enhancement relative to the bare GCE can be observed aer modication with AuNPs (Fig. 2Ac) . This can be attributed to electroactive surface enhancement, which is a well-reported phenomenon.
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Interestingly, a synergic enhancement in peak currents of up to 95% was obtained aer modication with the nanocomposite of MnO 2 NRs@AuNPs (Fig. 2Ad) . This resulted from the interplay of catalysis, conductivity and increase in surface area. Expectedly, there was about a 14% reduction in peak current signal when 25 mL of 500 ng mL À1 anti-AFP solution was immobilised on the surface of the GCE/MnO 2 NRs@AuNPs as depicted in Fig. 2Ae because of the non-conducting property of anti-AFP, which retarded electron transfer. This electrode was denoted as GCE/MnO 2 NRs@AuNPs/anti-AFP. Finally, the electrode was incubated with 0.25% bovine serum albumin for approximately 2 h in order to eliminate non-specic binding between antigen and electrode surface, a slight anodic shi in peak current signal and less than 5% reduction in peak current signal was observed (Fig. 2Af) . This electrode was labelled as MnO 2 -NRs@AuNPs/anti-AFP/BSA (the immunosensor). The events that occurred on the electrode surface was interrogated using electrochemical impedance spectroscopy (EIS) and Randle-Sevcik circuit model was used to t the EIS electrical parameters as shown in Table 1 . A similar trend to the voltammetric responses in Fig. 2A was observed when the various electrodes (in Fig. 2A ) were interrogated with EIS as depicted in Fig. 2B with the understanding that an increase in current denotes less resistant to ow of current (or lower charge transfer resistance). GCE/MnO 2 -NRs and GCE-AuNPs exhibited lower charge transfer resistance (R ct ) in comparison to the bare electrode (Fig. 2B ). This reduction in R ct agrees with the increase in peak currents signal obtained from the CV presented in Fig. 2A . The lowest charge transfer of 20.45 U was obtained for the nanocomposite as highlighted in (Fig. 2B and Table 1 ) and this result is in consonance with Fig. 2Ad where the highest currents were observed. As discussed earlier, the synergistic contribution of the nanocomposite increased both the surface area and the rate of electron ow rate thus providing a favourable interface for the redox reaction of the probe. The R ct increased on modifying with the antibody and BSA owing to the insulating nature of these species. The electrochemical changes in impedance were used as an indicator of successful fabrication of the immunosensor.
Optimisation of temperature and incubation time
The incubation temperature and time were optimised to ascertain the best performing conditions for the immunosensor. The effect of incubation temperature was interrogated from 20 to 45 C in the presence of 50 ng mL À1 AFP using square wave voltammetry (Fig. 3a) . The highest peak current was observed at 35 C and was thus selected as optimum temperature. The decline in current aer 35 C may be due to the denaturing of the protein (antibody). For optimal immunocomplex formation, the time of incubation was also investigated. As seen in Fig. 3b , the current seems to plateau aer 30 min. An optimum incubation time of 30 min was thus chosen. A similar incubation time has been reported for alphafeto protein immunosensor. 5 A pH of 7 was used as the optimum pH. 
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Detection of AFP by the immunosensor
Different immunosensors were fabricated on various platforms for the quantication of 500 ng mL À1 AFP as shown in (Fig. 4A) as a proof of concept, the highest peak current signal was obtained from the synergy of MnO 2 @AuNPs in comparison with other platforms. The MnO 2 @AuNPs immobilisation platform was thus employed for the fabrication of the immunosensor for the quantication of different concentrations of AFP. Under the optimised experimental parameters, the fabricated immunosensor was employed to quantify various concentrations of AFP. An inverse proportionality between the current and the AFP concentration was observed with voltammetry (Fig. 4B) . This is because the more the AFP bound unto the immunosensor, the more the barrier to the ow of charge due to the insulating property of the AFP or the antigen-antibody complex. On the other hand, EIS measurements show an increase in R ct with an increase in the concentration of the AFP (Fig. 4C) Table 2 ). The immunosensor reported in this work has the following advantages (i) it involves a two-step electrode preparation (ii) it has a wider linear range of 0.005 to 500 ng mL À1 (iii) the manganese nanorods used is low cost, relatively abundant, environmentally friendly and excellent electrochemical properties (iv) the quantication of AFP was carried out using SWV and EIS. The lower detection limit obtained must have been because of the synergic combination of the properties of both MnO 2 -NRs and AuNPs.
Stability, reproducibility and selectivity
To investigate the stability of the fabricated immunosensor, the current response was taken aer two weeks of storage at 4 C. A decrease in current response of 5.2% was observed (Fig. 5a ). This marginal current decrease suggests a good stability. To ascertain reproducibility of the proposed immunosensor, the current response was interrogated by the analysis of the same concentration of AFP (50 ng mL À1 ) using four different GCE prepared under the same experimental conditions as depicted in (Fig. 5b) . A relative standard deviation (RSD) of ca. 5.3% was calculated for the different measurements taken. In order to investigate the selectivity of the sensor, it was incubated with 100 ng mL À1 in the presence of the same concentration of interfering species (including ascorbic acid, prostate-specic antigen (PSA), D-glucose, carcinoembryonic antigen (CEA), urea, horseradish peroxidase (HRP) and human immunoglobulin (IgG)) (Fig. 5c.) . The current response due to the interfering substances was 5.8% less than the current change measured in the absence of interfering substances. In summary, the fabricated immunosensor displayed good reproducibility, stability and selectivity.
Application of the immunosensor
The application of the proposed immunosensor for the detection of AFP was examined by standard addition method using a human serum, which was diluted 100 times with PBS solution. The concentrations of AFP added to the diluted human serum samples were (10.0, 100.0 and 300.0 ng mL À1 ). Each of this sample was analysed ve times. The recovery was in the range of 99.98-100.03% and relative standard deviation of 0.0192-0.0847% (Table 3 ). This showed that the proposed immunosensor has a potential towards real quantication of AFP in a serum sample.
Conclusion
A novel nanocomposite of MnO 2 NRs and AuNPs was used as electrode material for the fabrication of an electrochemical immunosensor for a cancer biomarker AFP. A synergy between the nanocomposite yielded an AFP immunosensor with good detection limit, reproducibility and selectivity suggesting the favourable potential of this material combination. This work also laid a foundation for further exploration of the scarcely reported MnO 2 NRs in biosensors development. The detection limits obtained from both voltammetry and impedance are in agreement, lending the biosensor to dual transduction signals.
The possibility of a real application was carried out by detection of AFP in human serum. This fabricated immunosensor holds good promises for electrochemical immunosensor for different cancer biomarkers.
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